Research & KnowledgeEvent: September 2, 2026
Portfolio CMC Advisors published a new paper titled The Cost of Late Resolution: Why Manufacturing Problems Become Enterprise Problems
Published
Signal category
Research & Knowledge
Quote
“That distinction is at the center of my next paper: The Cost of Late Resolution™: Why Manufacturing Problems Become Enterprise Problems”
— Lonnie Robarge, Ph.D.|Portfolio CMC Advisors team
Company
Portfolio CMC Advisors
Preventing the Phase 2 Manufacturing Wall™ | Where CMC risk becomes business risk
- Industry
- Pharmaceutical Manufacturing
- Company size
- 2 employees
Portfolio CMC Advisors helps biotech companies identify and mitigate CMC risk before it impacts timelines, cost, or valuation. We specialize in early-stage strategy, scale-up risk, and translating development assumptions into manufacturable, regulatory-ready processes. Known for the “Phase 2 Manufacturing Wall™” framework.
Founded 2026